On ECHEMI
Home > Drugs > Beijing Xiehe Pharmaceutical Co., Ltd.
Beijing Xiehe Pharmaceutical Co., Ltd.
  • Founded in:

    1981-04-04
  • Country:

    China China
  • Address:

    Building 7, No. 37 Yongwang Road, Daxing Biomedicine Industry Base, Zhongguancun Science Park, Daxing District, Beijing
  • Tax NO.:

    91110115101618619W
  • Registered Funds:

    60 million yuan
  • Website:

  • Email:

Related Drugs
Granisetron Hydrochloride Injection
The main ingredient of this product is granisetron hydrochloride, and its chemical name is 1-methyl-N-(endo-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride.
Name Description Content CAS NO. Registered Holders
Granisetron Hydrochloride

It is a highly selective 5-HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. It inhibits the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. This product has high selectivity and no adverse reactions such as extrapyramidal reactions and excessive sedation.

More

It is a highly selective 5-HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. It inhibits the occurrence of nausea and vomiting by antagonizing the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. This product has high selectivity and no adverse reactions such as extrapyramidal reactions and excessive sedation.

107007-99-8 35
Paclitaxel Injection
5β,20-epoxy-1,2α,4,7β,10β,13α-hexahydroxytaxane-11-ene-9-one-4,10-diacetate-2-benzoate-13-[(2'R,3'S)-N-benzoyl-3-phenylisoserine ester
Name Description Content CAS NO. Registered Holders
Paclitaxel

This product is a new type of anti-microtubule drug. It promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. Paclitaxel is a mitotic inhibitor or spindle poison. It has a different mechanism of action from the commonly used chemotherapy drugs. It induces and promotes the assembly of microtubules. Paclitaxel has the effect of polymerizing and stabilizing microtubules, causing rapidly dividing tumor cells to be firmly fixed in the mitotic stage, blocking the replication of cancer cells and causing them to die.

More

This product is a new type of anti-microtubule drug. It promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. Paclitaxel is a mitotic inhibitor or spindle poison. It has a different mechanism of action from the commonly used chemotherapy drugs. It induces and promotes the assembly of microtubules. Paclitaxel has the effect of polymerizing and stabilizing microtubules, causing rapidly dividing tumor cells to be firmly fixed in the mitotic stage, blocking the replication of cancer cells and causing them to die.

33069-62-4 72
Paclitaxel Injection
The main ingredient of this product is paclitaxel.
Name Description Content CAS NO. Registered Holders
Paclitaxel

This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy.

More

This product is a new type of anti-microtubule drug that promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy.

33069-62-4 72
Felodipine Tablets
The main ingredient of this product is felodipine.
Name Description Content CAS NO. Registered Holders
Felodipine

Extract from the above information

More

Extract from the above information

86189-69-7 31
Felodipine Tablets
The main ingredient of this product is felodipine. Its chemical name is 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3-pyridinedicarboxylic acid ethyl ester methyl ester.
Name Description Content CAS NO. Registered Holders
Felodipine

When taking this product, taking drugs that affect cytochrome P450 at the same time can affect the blood concentration of felodipine. Enzyme inducers (such as phenytoin, carbamazepine, barbiturates) can cause a decrease in the blood concentration of felodipine. Enzyme inhibitors (cimetidine) can cause an increase in the blood concentration of felodipine. Although felodipine has a high degree of plasma protein binding, it does not affect the binding degree of other plasma protein-bound drugs (such as warfarin).

More

When taking this product, taking drugs that affect cytochrome P450 at the same time can affect the blood concentration of felodipine. Enzyme inducers (such as phenytoin, carbamazepine, barbiturates) can cause a decrease in the blood concentration of felodipine. Enzyme inhibitors (cimetidine) can cause an increase in the blood concentration of felodipine. Although felodipine has a high degree of plasma protein binding, it does not affect the binding degree of other plasma protein-bound drugs (such as warfarin).

86189-69-7 31
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.